Brachytherapy
Volume 8, Issue 3 , Pages 324-330 , July 2009

Photon activation therapy and brachytherapy

  • Brenda H. Laster

      Affiliations

    • Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel
    • Corresponding Author InformationCorresponding author. Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva 84105, Israel. Tel.: +972-8-646-1317; fax: +972-8-647-2955.
    • ,
  • Dabney W. Dixon

      Affiliations

    • Department of Chemistry, Georgia State University, Atlanta, GA
    • ,
  • Sara Novick

      Affiliations

    • Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel
    • ,
  • Jon P. Feldman

      Affiliations

    • Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel
    • ,
  • Veronique Seror

      Affiliations

    • Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel
    • ,
  • Zvi I. Goldbart

      Affiliations

    • Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel
    • Department of Analytical Chemistry, NRCN Negev, Beer Sheva, Israel
    • ,
  • John A. Kalef-Ezra

      Affiliations

    • Department of Medical Physics, Medical School, University of Ioannina, Ioannina, Greece

References 

  1. Santos MR, Callisen H, Winter J, et al. Radiation dose enhancement in tumors with iodine. Med Phys. 1983;10:75–78
  2. Hofer KG. Biophysical aspects of Auger processes: A review. Acta Oncol. 1996;35:789–796
  3. Hofer KG. Biophysical aspects of Auger processes. Acta Oncol. 2000;39:651–657
  4. Adam JF, Elleaume H, Joubert A, et al. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: First trial on rats bearing F98 gliomas. Int J Radiat Oncol Biol Phys. 2003;57:1413–1426
  5. Hall EJ. Radiobiology for the radiologist. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;
  6. Fairchild RG, Bond VP. Photon activation therapy. Strahlenther Onkol. 1984;758–763
  7. Biston MC, Joubert A, Adam JF, et al. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res. 2004;64:2317–2323
  8. Le Sech C, Takakura K, Saint-Marc C, et al. Strand break induction by photoabsorption in DNA-bound molecules. Radiat Res. 2000;153:454–458
  9. Le Sech C, Takakura K, Saint-Marc C, et al. Enhanced strand break induction of DNA by resonant metal-innershell photoabsorption. Can J Physiol Pharmacol. 2001;79:196–200
  10. Maeda M, Kobayashi K, Hieda K. Efficiencies of induction of DNA double strand breaks in solution by photoabsorption at phosphorus and platinum. Int J Radiat Biol. 2004;80:841–847
  11. Corde S, Balosso J, Elleaume H, et al. Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways. Cancer Res. 2003;63:3221–3227
  12. Corde S, Biston MC, Elleaume H, et al. Lack of cell death enhancement after irradiation with monochromatic synchrotron X rays at the K-shell edge of platinum incorporated in living SQ20B human cells as cis-diamminedichloroplatinum (II). Radiat Res. 2002;158:763–770
  13. Kobayashi K, Frohlich H, Usami N, et al. Enhancement of X-ray-induced breaks in DNA bound to molecules containing platinum: A possible application to hadrontherapy. Radiat Res. 2002;157:32–37
  14. Kobayashi K, Frohlich H, Usami N, et al. Enhancement of X-ray-induced breaks in DNA bound to molecules containing platinum: a possible application to hadrontherapy. Radiat Res. 2002;157:32–37
  15. Pignol JP, Rakovitch E, Beachey D, et al. Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compounds. Int J Radiat Oncol Biol Phys. 2003;55:1082–1091
  16. Usami N, Kobayashi K, Furusawa Y, et al. Irradiation of DNA loaded with platinum containing molecules by fast atomic ions C6+ and Fe26+. Int J Radiat Biol. 2007;83:569–576
  17. Rousseau J, Boudou C, Barth RF, et al. Enhanced survival and cure of f98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res. 2007;13:5195–5201
  18. Marzilli LG. Medical aspects of DNA porphyrin interactions. New J Chem. 1990;140:4090–4200
  19. Pasternack RF, Gibbs EJ. Porphyrin and metalloporphyrin interactions with nucleic acids. Metal Ions Biol Syst. 1996;33:367–397
  20. Dixon DW. Duplex DNA binding of nonplanar metal chelates of cationic porphyrins. In:  Lee M,  Strekowski L editor. Synthetic and biophysical studies of DNA binding compounds. Singpost Press; 2007;p. 239–262
  21. Brown E, Firestone RB, Shirley VS. Tables of radioactive isotopes. New York: John Wiley; 1986;
  22. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004;31:633–674
  23. Howell RW. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. 1992;19:1371–1383
  24. Humm JL, Howell RW, Rao DV. Dosimetry of Auger-electron-emitting radionuclides: Report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. 1994;21:1901–1915
  25. Rockwell SC, Kallman RF, Fajardo LF. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst. 1972;49:735–749
  26. Rockwell S, Kallman RF. Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res. 1973;53:281–294
  27. Dixon DW, Pu GM, Wojtowicz H. Capillary electrophoretic separation of cationic porphyrins. J Chromatogr A. 1998;802:367–380
  28. Barnes NR, Schreiner AF, Dolan MA. Measurement and interpretation of Q(0) and Q(1) band property changes of two cationic metalloporphyrins upon binding with B-DNA: Electronic MCD, CD, and optical absorption. J Inorg Biochem. 1998;72:1–12
  29. Dethlefsen LA, Prewitt JM, Mendelsohn ML. Analysis of tumor growth curves. J Natl Cancer Inst. 1968;40:389–405
  30. Peschel RE, Colberg JW, Chen Z, et al. Iodine-125 versus palladium-103 implants for prostate cancer: Clinical outcomes and complications. Cancer J. 2004;10:170–174
  31. Vaum R, Heindel ND, Burns HD, et al. Synthesis and evaluation of an 111In-labeled porphyrin for lymph node imaging. J Pharm Sci. 1982;71:1223–1226
  32. Foster N, Woo DV, Kaltovich F, et al. Delineation of transplanted malignant melanoma with indium-111-labeled porphyrin. J Nucl Med. 1985;26:756–760
  33. Maric N, Chan SM, Hoffer PB, et al. Radiolabeled porphyrin vs gallium-67 citrate for the detection of human melanoma in athymic mice. Int J Rad Appl Instrum B. 1988;15:543–551
  34. Pasternack RF, Brigandi RA, Abrams MJ, et al. Interactions of porphyrins and metalloporphyrins with single-stranded poly(dA). Inorg Chem. 1990;29:4483–4486
  35. Izbicka E, Wheelhouse RT, Raymond E, et al. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res. 1999;59:639–644
  36. Shi DF, Wheelhouse RT, Sun DY, et al. Quadruplex-interactive agents as telomerase inhibitors: Synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem. 2001;44:4509–4523
  37. Baumstark-Khan C, Heilmann J, Rink H. Induction and repair of DNA strand breaks in bovine lens epithelial cells after high LET irradiation. Adv Space Res. 2003;31:1583–1591
  38. Shin KH, Kang MK, Dicterow E, et al. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res. 2004;10:2551–2560
  39. Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148:435–438
  40. Ding M, Newman F, Raben D. New radiation therapy techniques for the treatment of head and neck cancer. Otolaryngol Clin North Am. 2005;38:371–395
  41. Grimard L, Esche B, Lamothe A, et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck. 2006;28:888–895

PII: S1538-4721(09)00196-2

doi: 10.1016/j.brachy.2008.12.008

Brachytherapy
Volume 8, Issue 3 , Pages 324-330 , July 2009

Article Tools

* Image Usage & Resolution